Brown S R, Park J H, Anderson J P. "一种的合成方法" [P]. US Patent, US 9816055 B2, 2024-10-01.
发明人林芳,王建平,周伟. "Method for the Synthesis of 5-Chloro-2-methoxy-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}benzene-1-sulfonamide" [P]. 中国发明专利, 专利号 CN 116984614 A, 授权公告日 2022-02-14.
发明人郭海燕,胡光,韩伟. "A Process for Preparing High-Purity 5-Chloro-2-methoxy-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}benzene-1-sulfonamide" [P]. 中国发明专利, 专利号 CN 117673318 A, 授权公告日 2016-07-25.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2014, 1621, 6217-6236.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2014, 1557, (1), 8808-8817.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 5-Chloro-2-methoxy-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}benzene-1-sulfonamide Using HRMS and NMR". Anal. Methods, 2014, 1340, 8551-8569.